|
Orthologous residues
|
|
ATRIP (human): S68‑p, ATRIP iso2 (human): S68‑p, ATRIP (mouse): S69‑p, ATRIP (rat): S69‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, phospho-antibody
|
|
Relevant cell lines - cell types - tissues:
A549 (pulmonary) [ATRIP (human)], HeLa (cervical) [ATR (human)], HeLa (cervical) [ATRIP (human)]
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
ATR (human)
|
transfection of inactive enzyme, co-immunoprecipitation
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
hydroxyurea
|
|
|
|
increase
|
|
|
UV
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
intracellular localization
|